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ABSTRACT 
   
Strict regulation of cytosolic Ca2+ is essential to regulated exocytosis and proper 
pancreatic acinar cell function, controlled in part by pumps that shuttle Ca2+ out of the 
cytosol.  Our laboratory identified a novel isoform of Secretory Ca2+ ATPase 2 (SPCA2) 
containing only the carboxy terminus.  Pancreatic SPCA2, is an approximately 17-20 
kDa, protein encoded by the Atp2c2 gene and is completely absent in Mist1-/- acini.  The 
focus of this thesis was to understand the transcriptional regulation of Atp2c2 in the 
pancreas.  Pancreatic Atp2c2 appears to be transcribed from an alternative transcriptional 
start site (TSS) and regulated by MIST1. Bioinformatic analyses identified a truncated 
Atp2c2 isoform initiated within the 23rd intron of the Atp2c2 gene.  Comparative analysis 
suggested this isoform differs between humans and mice. ChIP-seq analysis identified 
enrichment for trimethylated (Me3) histone 3(H3) at lysine 4 (K4) in intron 23 in 
pancreatic tissue, which was confirmed by ChIP-qPCR. ChIP-qPCR also identified 
enrichment of Acetylated Histone 3 (H3Ac), H3K36Me3, MIST1 and RNA Pol II within 
this region. Luciferase assays and immunofluorescence confirmed this region possessed 
promoter activity and produced a protein of the correct size. Our results identify a unique 
TSS for Atp2c2 within the pancreas that is regulated by MIST1.  	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1.1 The Pancreas 
The pancreas is a branched, glandular organ located in the upper abdominal 
cavity, which consists largely of exocrine tissue in addition to portions of endocrine 
tissue termed the Islets of Langerhans (Arda, Benitez, & Kim, 2013). The Islets of 
Langerhans are made up of five cells types, which are identified by their production and 
secretion of different hormones. These cell types include β cells, which produce and 
secrete insulin to lower blood glucose, α cells, which make and secrete glucagon, δ cells, 
which produce and release somatostatin, ε cells, which produce and release ghrelin, and 
pancreatic polypeptide (PP) cells, which regulate pancreatic secretion (Hezel et al., 
2008).  
The exocrine portion of the pancreas, which is the focus of this thesis, is required 
for the digestion of fats, carbohydrates, and proteins. The exocrine pancreas is 
responsible for the secretion of more than 20 digestive enzymes and is composed of 
acinar and ductal cells. Acinar cells are serous exocrine epithelial cells that form grape-
like clusters and secrete digestive enzymes and sodium chloride rich fluid into the 
branched tubes formed by ductal cells (Low, Shukla, & Thorn, 2010). Pancreatic ductal 
cells produce bicarbonate that aids in carrying zymogen granules to the duodenum 
through the common bile duct and counteracts the acidic secretions coming from the 
stomach (Arda et al., 2013). Acinar cells produce digestive enzymes such as proteases, 
amylase, lipase, secretin, and cholecystokinin, and package these in the form of zymogen 
granules (ZG). These cells are highly polarized with basally located nuclei and 
endoplasmic reticulum (ER) and apically directed zymogen secretion (Dingsdale, 
Voronina, Haynes, Tepikin, & Lur, 2012; Hezel et al., 2008) [Figure 1.1].  
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1.2 Acinar Regulated Exocytosis 
Acinar regulated exocytosis involves stimulus-secretion coupling in which 
parasympathetic or hormonal stimulation of acinar cells results in secretion.  The primary 
stimulants for acinar cell secretion are parasympathetic cholinergic input and actions of 
the hormone cholecystokinin causing an increase in intracellular free calcium (Ca2+). The 
increase in cytoplasmic Ca2+ acts as the primary signaling mechanism for secretion (Low 
et al., 2010; Williams, 2001, 2011). Local increases in Ca2+ at the apical border result in 
fusion of ZGs to the apical pole of the acinar cell where they can fuse with the membrane 
and release their contents into the duct (Low et al., 2010; O H Petersen, 2009). ZG fusion 
to the membrane is mediated through soluble N-ethylmalemide-sensitive fusion protein 
attachment protein receptors (SNAREs). This initial Ca2+ release appears to come from 
intracellular stores and is followed by Ca2+ efflux and additional influx through store 
operated calcium channels located in the basolateral membrane (Williams, 2001; Yule, 
2010).   
The acinar cell response to heightened intracellular Ca2+ levels is multifaceted and 
involves Ca2+ oscillations, waves, and local spikes (Low et al., 2010; Wäsle & 
Edwardson, 2002). These changes in intracellular Ca2+ are the result of tightly regulated 
control of intracellular Ca2+ stores within the endoplasmic reticulum and mitochondria, 
extracellular Ca2+ accumulations, and channels involved in Ca2+ release such as inositol 




Secretegogue Stimulated Ca2+ Release 
  The main secretegogues in pancreatic acinar cells are the neurotransmitter 
acetylcholine (Ach), which activates the muscarinic cholinergic receptor M3, and the 
hormone cholecystokinin (CCK) (Ole H Petersen, 2012). The receptors for these 
secretegogues are all heterotrimeric G protein coupled receptors of the Gq family. 
Binding of ligand induces an intracellular conformational change in the receptor, which 
results in activation of the G protein via the binding of GTP. This causes dissociation of 
the α-subunit of the heterotrimeric G protein and activates phospholipase-c (PLC). 
Phosphatidylinositol 4,5-bisphosphate (PIP2) is cleaved by PLC into inositol 1,4,5-
triphosphate (IP3), which bind ligand gated Ca2+ channels (IP3 receptors), leading to the 
release of Ca2+ from the ER. All three IP3Rs are expressed in acinar cells with IP3R2 and 
IP3R3 making up 90% of channels and IP3R1 making up only 10% (Yule, 2010).  After 
release of ER Ca2+ stores, Ca2+ ATPases extrude Ca2+ from the cytoplasm by effluxing it 
out of the cell and moving Ca2+ back into intracellular stores. Some Ca2+ is pumped back 
into the ER stores but stores are not fully replenished because of Ca2+ lost through efflux. 
These stores are maintained via store operated Ca2+ channels allowing Ca2+ entry at the 
basolateral membrane (Hewavitharana, Deng, Soboloff, & Gill, 2007; Williams, 2001; 
Yule, 2010). 
  In response to secretegogues, Ca2+ oscillations appear to be mediated through 
IP3R. It is also suggested that independent regulators of Ca2+ such as nicotinic acid 
adenine dinucleotide (NAADP) and cyclic ADP ribose (cADPR), may be responsible for 
these oscillations via signaling through two pore channels (TPCs) and ryanodine 
receptors, respectively. TPCs are located on lysosomes and release endo-lysosomal Ca2+ 
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stores in response to NAADP binding. cADPR activates ryanodine receptors resulting in 
the amplified release of ER Ca2+ stores (Zhao, Graeff, & Lee, 2012). Oscillations initially 
occur at the apical pole of the acinar cell where they are believed to stimulate regulated 
exocytosis (Williams, 2001).  Abnormal accumulation of Ca2+ within the cytosol can 
have numerous effects on cell function, physiology and pathology.  
 
1.3 Calcium and the Cell 
Ca2+ plays a critical role in many cellular processes and has been identified as one 
of the most important and versatile second messengers, important in conveying 
extracellular signals into intracellular responses (Skupin & Thurley, 2012). Ca2+ signaling 
can result in both long term changes such as regulation of transcription, proliferation, and 
cell division, or transient responses such as exocytosis and contraction (Hewavitharana et 
al., 2007).  The ability of Ca2+ to act as a vital second messenger is afforded by the 
maintenance of a calcium gradient across the cell membrane, with high levels of 
extracellular Ca2+ and high levels of Ca2+ in intracellular compartments such as the ER, 
sarcoplasmic reticulum (SR), mitochondria, Golgi, endosomes, lysosomes, and secretory 
granules and maintenance of low levels of cytoplasmic Ca2+. For cells to utilize the Ca2+ 
gradient, they must maintain intracellular levels by expelling, compartmentalizing, and 
chelating Ca2+ (Clapham, 2007).  I have already described the process by which Ca2+ 







Ca2+ATPases are crucial in maintaining the Ca2+ gradient between the 
intracellular and extracellular environments by pumping Ca2+ out of the cytosol. They 
help to restore cytoplasmic Ca2+ to basal levels after cell stimulation and help maintain 
Ca2+ stores in the ER, Golgi, and other compartments (Wuytack, Raeymaekers, & 
Missiaen, 2002). The three families of Ca2+ ATPases are the sarcoendoplasmic reticular 
Ca2+ ATPases (SERCA), plasma membrane Ca2+ ATPases (PMCA), and secretory 
pathway Ca2+ ATPases (SPCA). All three of these are P-type Ca2+ ATPases with PMCAs 
being the oldest phylogenetically, followed by the SPCAs and then the SERCAs 
(Vandecaetsbeek, Vangheluwe, Raeymaekers, Wuytack, & Vanoevelen, 2011). SERCA 
pumps are responsible for pumping Ca2+ from the cytosol into the ER and PMCAs are 
responsible for pumping Ca2+ from the cytosol out of the cell (Clapham, 2007). The less 
studied SPCAs are found within the Golgi membrane and pump Ca2+ from the cytosol 
into the Golgi (Vanoevelen et al., 2005). Ca2+ ATPases exist as different isoforms and 
splice variants allowing them to function in highly specialized ways in different cell types 
and allowing the strict regulation of Ca2+ levels required.  
 
Sarcoendoplasmic Reticular Ca2+ ATPases (SERCA) 
Sarcoendoplasmic Reticular Ca2+ ATPases contribute to maintaining ER stores of 
Ca2+ and lowering cytoplasmic Ca2+ levels to resting levels. These ATPases are 
transcribed from the ATP2A gene family and contain two Ca2+ binding sites, transporting 
two Ca2+ at the expense of one adenosine triphosphate (ATP). SERCA2 is the most 
widely expressed SERCA and is expressed in cardiac muscle, fast twitch skeletal muscle, 
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smooth muscle, and cerebellar neurons. SERCA2 exists as four different isoforms: 
SERCA2a, 2b, 2c, and 2d, the products of alternative splicing. SERCA2b is considered 
the housekeeping SERCA and SERCA2a is the muscle specific isoform found in cardiac, 
skeletal and smooth muscle. SERCA2c and SERCA2d were more recently discovered in 
the heart (Vandecaetsbeek et al., 2011). SERCA1 is the most specialized SERCA and is 
highly expressed in fast-twitch skeletal muscle. SERCA1 is expressed in two isoforms: 
SERCA1a is expressed in adults and SERCA1b is expressed in neonates and adult 
muscle undergoing regeneration (Vandecaetsbeek et al., 2011). SERCA3 seems to be a 
highly specialized SERCA that is always coexpressed with SERCA2b. SERCA3 has six 
splice variants in humans (SERCA3a-f) and three splice variants in mice (SERCA3a-c). 
It is expressed in secretory cells including the trachea, pancreas, colon, lymphocytes, 
platelets, mast cells and thyroid (Vandecaetsbeek et al., 2011; Wuytack et al., 2002). 
 
Plasma Membrane Ca2+ ATPases (PMCA) 
  Plasma membrane Ca2+ ATPases lower intracellular Ca2+ by pumping Ca2+ out of 
the cytosol. These pumps are expressed from the ATP2B genes as four different isoforms: 
PMCA1, 2, 3, and 4. PMCA1 is ubiquitously expressed beginning in the earliest stages of 
the embryo. PMCA2 and PMCA3 have a more restricted expression profile with PMCA2 
expressed in the lactating mammary gland, PMCA3 expressed in skeletal muscle and 
both expressed in the nervous system. PMCA4 has a more widespread tissue expression 
found in the heart, brain and at high concentrations in the spermatozoa (Giacomello, De 
Mario, Scarlatti, Primerano, & Carafoli, 2013).  The PMCAs are expressed as over 30 
different isoforms resulting from alternative splicing of their primary transcripts. These 
	  	  
10	  
various splice variants result in isoforms, which have more tissue specific cellular 
localization, tissue specific Ca2+ regulating abilities, and differences in calmodulin 
affinity (Di Leva, Domi, Fedrizzi, Lim, & Carafoli, 2008).  
 
Secretory Pathway Ca2+ ATPases (SPCA) 
 Secretory pathway Ca2+ ATPases (SPCAs) are found within the membrane of the 
Golgi and are responsible for pumping Ca2+ and manganese (Mn2+) ions from the cytosol 
into the Golgi to be utilized for proper protein sorting, processing, and glycosylation. 
Similar to PMCAs the SPCAs contain only a single ion binding site (Vandecaetsbeek et 
al., 2011). Two SPCAs are found in higher vertebrates: SPCA1 and SPCA2. SPCA1 is 
transcribed from ATP2C1, which is located on chromosome 3 in humans. This protein is 
expressed in all cell types and tissues that were studied and thus appears to be the 
housekeeping Ca2+ /Mn2+ pump. ATP2C1 is alternatively spliced into four proteins 
SPCA1a-d, they differ in only their carboxyl termini and all are functional with the 
exception of SPCA1c. ATP2C1 is the gene that is associated with the skin disorder 
Hailey-Hailey disease and the absence of this gene results in embryonic lethality by 
embryonic day 10.5 due to widespread cell apoptosis, caused by the inability of the Golgi 
to handle Mn2+ and Ca2+ (Okunade et al., 2007; Vandecaetsbeek et al., 2011; Vanoevelen 
et al., 2005). There is a second SPCA protein (SPCA2) that has much more limited 





1.4 Secretory Pathway Ca2+ ATPase 2 (SPCA2) 
SPCA2 is a protein of approximately 103 kilo Daltons (kDa) and is transcribed 
from the Atp2c2 gene, which consists of 27 exons. Atp2c2 is located on chromosome 8 in 
mice and chromosome 16 in humans with a restricted tissue expression. While SPCA2 
can transport both Ca2+ and Mn2+ ions, it has been shown to have a much higher affinity 
for Ca2+ (Dode et al., 2006). SPCA2 displays a restricted tissue distribution, which 
includes the brain, colon, prostate, lactating mammary gland, salivary glands, testes, and 
the pancreas (Vanoevelen et al., 2005). The expression of this protein is primarily 
restricted to cells with highly active exocytosis systems suggesting it may play a role in 
cellular secretion. SPCA2 is highly upregulated in the mammary gland during lactation, 
and is responsible for lowering prolactin induced increased intracellular Ca2+ levels by 
pumping Ca2+ into the Golgi (Anantamongkol, Takemura, Suthiphongchai, Krishnamra, 
& Horio, 2007; M. Feng et al., 2011). 
  Interestingly SPCA2 expression is also increased in human breast cancer 
derived cell lines and human breast tumors conferring an increase in intracellular Ca2+ 
levels and increased tumorigenicity, suggesting other potential roles for this protein in 
cellular Ca2+ maintenance. Importantly, the SPCA2-mediated Ca2+ signaling was 
independent of ER and Golgi stores and was found to interact with the store operated 
calcium channel Orai1 at the plasma membrane to activate downstream Ca2+ signaling. 
This Ca2+ signaling ability was dependent on the expression of positively charged lysines 
927, 931, and 937 and arginine 938 and a putative PDZ domain found in the C-termini of 
the protein, which are conserved between human, rat, and mouse. This role of SPCA2 in 
increasing intracellular Ca2+ levels is in contrast to the usual role of Ca2+ATPase pumps 
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in lowering intracellular Ca2+ levels suggests it may play an important physiological role 
in secretory tissues (M. Feng et al., 2011). 
  Previous work from our lab showed that SPCA2 expression in the pancreas is 
restricted to the acinar cells and a subset of islet cells, and is not found in the ducts, 
intercalated ducts, or blood vessels. Surprisingly, SPCA2 is localized to the basolateral 
portion of the acinar cell, a pattern that is consistent with localization to the ER instead of 
the Golgi. In addition, the pancreatic Atp2c2 transcript and SPCA2 protein are both much 
smaller than expected. The protein detected in the pancreas is approximately 20 kDa in 
size and includes at least exons 24 to 27 [Figure 1.2].  Since this is a truncated form of 
SPCA2, we have termed it SPCA2c (Garside et al., 2010). SPCA2c can be recognized 
using an antibody generated to the carboxyl terminus of the full-length protein.  All of 
these differences suggest that SPCA2c may be performing a different function than the 
full-length isoform. 
  SPCA2 was found to be highly upregulated in lactating mouse mammary gland in 
conjunction with elevated expression of the store operated calcium channel Orai1 
channel. Orai1 and SPCA2 colocalize at the plasma membrane in the lactating mammary 
gland mediating Ca2+ influx into the basal membrane of these cells. It appears that this 
Ca2+ influx occurs by a mechanism termed store independent Ca2+ entry (SICE). 
Knockdown of SPCA2 inhibited localization of Orai1 to the plasma membrane and 
instead, Orai1 localized to the perinuclear membrane. The converse was also true for 
SPCA2 when Orai1 was knocked down (Cross, Breitwieser, Reinhardt, & Rao, 2013). 
The full-length isoform of SPCA2 appeared to be more effective in localizing Orai1 at 
the plasma membrane and amino acids 67 to 106 in the protein effectively interacted with 
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Orai1.  However, this interaction did not elicit Ca2+ influx, suggesting that the amino 
terminus plays a role in localization to the plasma membrane and the carboxyl terminus 
plays the crucial role in Ca2+ entry(M. Feng et al., 2011). This theory is further supported 
by the fact that tethering the carboxyl terminus of the protein (SPCA2c) allows 
interaction with Orai1 and Ca2+ influx, but free SPCA2c is unable to effectively localize 
with Orai1 at the plasma membrane. In culture, the loss of SPCA2 also inhibited the 
formation of mammospheres suggesting that it may also play a role in structural 
organization of secretory acini (Cross et al., 2013).  
  It appears that in lactating mammary gland SPCA2 and Orai1 interact in a manner 
to allow SICE, and if this type of Ca2+ entry becomes hyperactive, this results in cell 
dedifferentiation and tumorigenesis (M.-Y. Feng & Rao, 2013). In the pancreas however 
the loss of SPCA2c is associated with high intracellular Ca2+ levels (Garside et al., 2010). 
In the pancreas it appears that SPCA2c is unlikely to interact with Orai1 at the plasma 
membrane suggesting it may be involved in regulating intracellular Ca2+ levels via a 
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1.5 Store Operated Ca2+ Entry 
  Stromal interaction molecules (STIMs) and Orai proteins work together in 
mediating the SOC pathway and in replenishing diminished ER Ca2+ stores.   STIM1 is a 
single membrane spanning protein that acts as a sensor to detect lowered levels of Ca2+ in 
ER stores and is expressed at the cell membrane and ER membrane. Orai1 is a four 
transmembrane domain SOC channel localized to the plasma membrane with both its 
carboxyl and amino termini found in the cytoplasm. STIM1 interacts with the c-terminus 
of Orai1 and together they allow Store operated Ca2+ entry (SOCE) into the cell to 
replenish ER stores (Collins, Zhu-Mauldin, Marchase, & Chatham, 2013; Hong et al., 
2011). In pancreatic acinar cells STIM1 is located in the ER membrane and upon 
stimulation it translocates to the plasma membrane via ER puncta. Orai1 is located at the 
apical, basal, and lateral membranes of the pancreatic acinar cell, and basal and lateral 
Orai 1 have been shown to interact with STIM1 to allow Ca2+ influx for replenishment of 
ER Ca2+ stores. The highest density of Orai1 channels are however found located at the 
apical membrane though there is not a clear consensus on what the role of these apical 
Orai1 channels is. Hong et. al. (2011) observed moderate co-localization, approximately 
40%, of Orai1 at the apical pole with STIM1suggesting it may be involved in SOCE. 
Dingsdale et. al. (2012) however did not observe any co-localization with STIM1 at the 
apical membrane, suggesting that Orai1 may function in a store operated Ca2+ 
independent manner at the apical membrane of pancreatic acinar cells. Due to SPCA2c’s 
structure and localization, it seems that its role in pancreatic acinar cells is more complex 
than other Ca2+ATPases.  However, before functional studies can be addressed, including 
targeted gene ablation, it is important to understand the complete coding region for 
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SPCA2c.  The main question this thesis will address is whether SPCA2c is the result of 
alternative splicing or a novel transcriptional start site. Knowing this will also enable 
researchers to understand how it is regulated 
 
1.6 Gene Regulation in the Pancreas 
  Transcription begins with the binding of RNA Polymerase II (RNA Pol II). 
Regulation of transcription is controlled at two levels: at the level of transcription factors 
and transcriptional apparatus and secondly via chromatin and its regulators (Lee & 
Young, 2013). The development of the pancreas begins with dorsal budding of the 
embryonic posterior foregut endoderm and various transcriptional cascades drive the 
development of the endoderm dorsal bud into the pancreas.  Pancreatic progenitor cells 
expressing TF pancreatic and duodenal homeobox (Pdx) 1 followed by expression of 
bHLH TF pancreatic transcription factor (Ptf) 1a, arise in the mouse on embryonic day 
9.0 (Arda et al., 2013). By embryonic day 12.5 continued branching divides the 
populations into tip progenitor cells which become acinar cells and trunk cells which give 
rise to ductal and endocrine cell populations (Cleveland, Sawyer, Afelik, Jensen, & 
Leach, 2012). The Ptf1-J heterotrimeric complex consisting of the transcription factors 
Ptf1, Tcf12, and Rbpj forms, which drives acinar cells fate and maturation (Benitez, 
Goodyer, & Kim, 2012). The mature acinar cell phenotype is maintained by the Ptf1-L 
complex consisting of the TFs Ptf1a, and Rbpj1, which is required for the expression of 
genes encoding mitochondrial machinery, enzyme production, and exocytosis 




MIST1 and Atp2c2 Transcriptional Regulation 
  MIST1 is a basic helix loop helix (bHLH) transcription factor (TF) expressed in 
serous exocrine tissues. MIST1 induces expression of genes necessary for secretory 
function and regulated exocytosis (Capoccia et al., 2011; Pin, Rukstalis, Johnson, & 
Konieczny, 2001; Tian et al., 2010). MIST1 binds to E-box consensus sites (CANNTG) 
and recently ChIP-Seq revealed in pancreas MIST1 prefered binding to an internal TA or 
GC (Direnzo et al., 2012).It is required for the full maturation and function of pancreatic 
acinar cells. Mist1-/- mice display disrupted acinar cell polarity and regulated exocytosis 
(Pin et al., 2001).  Aberrant Ca2+ signaling is common to most models of pancreatic 
injury. In Mist1-/- mice, all Ca2+ ATPases are normally expressed with the exception of 
SPCA2, which is absent suggesting that MIST regulates SPCA2 expression (Garside et 
al., 2010).  
 
RNA Polymerase (RNA Pol) 
  Eukaryotic RNA Polymerases are large proteins made up of 12 subunits. 
There are three classes of transcription in eukaryotic cells: ribosomal RNA (rRNA) 
transcription, messenger RNA transcription (mRNA) and transfer RNA (tRNA). The 
enzyme RNA Pol I transcribes rRNA in the nucleolus, RNA Pol II transcribes mRNA in 
the nucleoplasm for eventual translation into protein, and RNA Pol III transcribes small 




RNA Polymerase II Driven Transcription 
  Initiation of transcription begins at the promoter, which is found immediately 
upstream (51) of the transcriptional start site (TSS). The promoter region is a sequence 
larger than 200 bps, which contains binding elements for TFs required for transcription 
initiation and RNA Pol II recruitment (Lewin, 2008). About 60% of human promoters 
contain a high CpG content that are termed CpG islands. These regions remain 
unmethylated in active genes but may be methylated in mature and differentiated cells 
not expressing these genes (Jiang, Liu, Chen, Cao, & Tao, 2013).  The General RNA Pol 
II driven TFs (TFIIX) make up the basal transcription apparatus and there are seven core 
promoter element sequences found within 50 bps of the TSS, which allow them to bind at 
the promoter forming the transcription preinitiation complex (PIC).  
  Less than 1/3 of human genes contain an Adenine (A) and Thymine (T) rich 
sequence known as the TATA box [TATA(A/T)A(A/T)(A/G)] which is found 25 to 30 
bps upstream of the TSS which allows binding of TATA-binding protein (TBP) and 
formation of the PIC at this region. In TATA-less promoters TBP is associated with other 
DNA binding proteins allowing it to be recruited to the promoter. The Initiator  (Inr) 
element is found surrounding about 80% of TSS and is a pyrimidine rich sequence 
[(C/G)(C/G)AAN(A/T)(C/G)(C/G)] that recruits TBP associated factors (TAF)s 1 and 2 
to the PIC. The downstream promoter element (DPE) [(A/G)G(A/T)CGTG] is found +29 
to +35 bps from the TSS in about 25% of promoters and recruits TAF6 and TAF9. 
Additionally the upstream transcription factor-RNA Pol II driven element B (BREU) 
[(G/C)(G/C)(G/A)CGCC]  and the downstream transcription factor-RNA Pol II driven 
element B (BREd) [(G/A)T(T/G/A)(T/G)(G/T)(T/G)(T/G)] can also be found in the 
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promoter of about 28% of genes to aid in transcription initiation by recruiting TFIIB. 
Additionally the motif ten element (MTE) [C(G/C)A(A/G)C(G/C)(G/C)AACG(G/C)] 
and the downstream core element (DCE) are also found downstream of the TSS. The 
DCE is composed of three subelements SI (CTTC) found 6 to 11 bps downstream, SII 
(CTGT) at 16 to 21 bps downstream, and SIII (AGC) found 30 to 34 bps downstream of 
the TSS and acts to recruit TAF1 (Thomas & Chiang, 2006).  
  Assembly of the PIC begins with binding of TFIID, which is made up of TBP and 
multiple tissue specific TAFs. TFIIA and TFIIB are then recruited to stabilize TFIID 
binding. RNA Pol II and TFIIF are then recruited forming a stable complex. TFIIE and 
TFIIH are then recruited and transcription can begin. Transcription of tissue specific 
genes in controlled by upstream sequence elements that bind specific TFs allowing 
assembly of the PIC only in tissues expressing the necessary TFs (Lewin, 2008; Thomas 
and Chiang, 2006). 
 
1.7 Epigenetic Transcriptional Regulation 
  Epigenetics is the study of heritable changes in gene regulation and expression 
without any changes to DNA sequence (Capell & Berger, 2013). Epigenetic changes are 
the basis for varied gene expression profiles allowing for diverse cell types and tissue 
types in complex organisms (Moore, Le, & Fan, 2013). The basis of epigenetic control 
results from the organization of DNA into chromatin. DNA is highly compacted into 
chromatin by first wrapping it around eight histone proteins (H) including two of each of 
the core histones H2A, H2B, H3, and H4. This histone wrapped DNA is referred to as a 
nucleosome, which is further, compacted into chromatin by further coiling that requires 
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H1 (Lewin, 2008). Epigenetic modifications occur through direct modifications to the 
DNA such as methylation or through posttranslational modifications to histone proteins 
affecting the interaction between DNA and histones (Capell & Berger, 2013). 
 
DNA Methylation   
  DNA can be epigenetically altered by methylation of cytosines, which often 
occurs at CpG sites. Four types of cysteine methylation exist: 5-methylcytosine, 5-
hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine. DNA methylation is 
associated with several important physiological processes including genomic imprinting, 
X-chromosome inactivation, gene regulation, and chromatin stabilization. Gene 
methylation levels have been shown to change in response to environmental factors 
subsequently resulting in altered gene expression. Increased DNA methylation has been 
associated with gene silencing and recruitment of RNA Pol II is associated with 
demethylation (Jiang et al., 2013).  
  Three functional DNA methyltransferases (DNMTs) enzymes have been 
identified in eukaryotic cells: DNMT1 which maintains DNA methylation patters during 
DNA replication, and DNMT3a and DNMT3b, which methylate DNA during 
development and form new methylation patterns on unmodified DNA (Moore et al., 
2013). DNMT3a methylation also prevents the addition of gene silencing histone marks, 





Chromatin exists in active and inactive states. Activity can be conferred by post 
translation histone modifications, such as methylation, acetylation, ubiquitylation, 
glycosylation, and phosphorylation that regulate the accessibility of DNA (Capell & 
Berger, 2013; Lelli, Slattery, & Mann, 2012).  Accessible DNA is more open to TF 
binding allowing increased transcriptional activity. Methylation of histones can be 
associated with both active and repressed genes depending on its location. 
Phosphorylation of histones weakens bonds the interaction between DNA and histones 
having roles in DNA repair, development and altering affinity of chromatin binding 
proteins. Glycosylation of histones by β-N-acetylglucosamine has been observed on 
histones H2A, H2B, and H4 but the effect of glycosylation on gene expression remains to 
be elucidated. Histone acetylation is a highly dynamic process that is carried out by 
histone acetylases and deactylases, both of which are linked to transcriptional activation. 
Acetylation of histones loosens their interaction with DNA making DNA more available 
for binding of polymerase and transcriptional machinery, thereby increasing the potential 
for transcription (Zentner & Henikoff, 2013). 
Histone 3 is an important core histone involved in creating nucleosome structure 
and modifications of this histone mark active and silenced promoters. Active TSSs are 
marked by acetylation (H3Ac), methylation of Histone 3 Lysine (K) 4 (H3K4Me1, 
H3K4Me2, and H3K4Me3), and histone 3 lysine 36 trimethylation, (H3K36Me3) while 
silenced promoters are marked by trimethylation of lysine 27 (H3K27Me3) and Histone 3 
lysine 9 trimethylation (H3K9Me3) (Rye, Sætrom, Håndstad, & Drabløs, 2011). These 
marks are found upstream of the transcriptional start site (TSS) (Heintzman et al., 2007).  
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Despite being associated with active genes loss of H3K4Me3 and H3K36Me3 does not 
appear to have a direct effect on transcriptional activity, suggesting that these 
modifications may not promote transcription but rather prevent the addition of silencing 
marks. H3K27Me3 and H3K9Me3 on the other hand promote formation of 
heterochromatin and stabilize nucleosome structure which inhibits binding of polymerase 
and other transcriptional machinery (Zentner & Henikoff, 2013).  
 
1.8 Hypothesis and Objectives 
  The loss of MIST1 is associated with disruptions in Ca2+ movement and 
decreased acinar regulated exocytosis. Expression of the Ca2+ ATPase Atp2c2/SPCA2 is 
lost in the absence of MIST1 and SPCA2 expressed in the pancreas is much smaller than 
previously characterized suggesting that this represents a splice variant or novel isoform 
transcribed from an alternative transcriptional start site. 
I hypothesize that Atp2c2-c found in pancreatic acinar cells is transcribed from a novel 
TSS and that its expression is regulated by MIST1.  
  The aims of my project are to define the transcriptional start site and promoter of 
the truncated Atp2c2 (Atp2c2-c) isoform and define factors involved in Atp2c2c gene 






























  All of the mice used were of a C57Bl/6 background. The targeted deletion of the 
Mist1 gene has previously been described (Pin et al., 2001). For all studies, 2 to 4 month 
old male animals were used. The mice were handled according to the regulations set by 
the protocol for The University of Western Ontario by The Canadian Council of Animal 
Care (protocol #2008-116).  
 
1.10 Chromatin Isolation, and ChIP 
 
Acinar Cell Chromatin Isolation 
  Mice were sacrificed with 95% CO2 with 5% O2 and the pancreata were carefully 
dissected out with the removal of any residual fat or non-specific tissue and placed in 5 
mL of oxygenated DMEM media containing 0.1 mg/ml collagenase (Sigma, St. Louis 
MO). Pancreata were injected 6 times with oxygenated DMEM using a syringe. The 
injected pancreata were then cut into small pieces, oxygenated for 1 minute, and 
incubated in collagenase/DMEM solution for 40 minutes in a 37°C water bath, shaking at 
100 rpm. A plastic transfer pipette was used initially and then a 5 mL pipette to gently 
break apart the tissue. Tissue in collagenase/DMEM was gravitationally passed through a 
nylon filter (Millipore, Temecula CA) into a 50 mL conical tube (BD Falcon, Pittston 
PA). The nylon filter was washed with 40 mL DMEM containing 4% BSA. Tubes were 
centrifuged at 500 rpm for 4 minutes using the Eppendorf Centrifuge 5804 R. The 
supernatant was gently pipetted off.  
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 To crosslink proteins to the DNA, 10 mL of DMEM with 1% formaldehyde 
(Ricca Chemical Company, Arlington TX) was added to the cells. This mixture was 
placed on the Thermolyne RotoMix Type 48200 shaker for 10 minutes. After 10 minutes 
0.13 M glycine was added and tubes were placed on the shaker for 5 minutes. After 5 
minutes, the cell pellet mixture was centrifuged for 3 minutes at 1500 rpm. The 
supernatant was removed and the cell pellet washed two times with 10 ml of phosphate 
buffered saline (PBS) and spun down for 3 minutes at 1500 rpm. PBS was removed and 
500 mL of cytoplasmic extract (CE) buffer was added to cells to isolate the nuclei. CE 
buffer cell mixture was homogenized for 5 rounds with the tissue homogenizer and then 
incubated on ice for 15 minutes in a 1.5 ml Eppendorf tube. Tubes were centrifuged at 
4°C at 5000 rpm for 10 minutes. The supernatant was removed and nuclei resuspended in 
500 µl sodium dodecyl sulfate (SDS) lysis buffer with 2.5 µg/µl of each, aprotinin, and 
pepstatin A. Samples were incubated on ice for 15 to 20 minutes and then split into 
volumes of 200-300 µl per tube to be sonicated as stated below.  
 
 
Chromatin Isolation from Whole Pancreas 
  Mice were sacrificed with 95% CO2 with 5% O2 and the pancreata were dissected 
out with the removal of any residual fat or non-specific tissue and placed in DMEM 
media warmed to 37°C. The injected pancreata were then cut into small pieces, added to 
40 mL of media with 1% formaldehyde, and gently rocked at room temperature for 10 
minutes. To stop the crosslinking process, 2 ml of 2.5M glycine was added and the 
sample gently rocked for 5 minutes at room temperature. Samples were centrifuged at 
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720 rpm for 2 minutes at 4°C. Supernatant was removed and the pellet was washed with 
40 ml of ice cold PBS containing 5 µg/µl of each leupeptin, aprotinin, and pepstatin A. 
The samples were centrifuged at 720 rpm and the wash was repeated. Samples were then 
treated with 1 ml of CE buffer containing 5 µg/µl of each leupeptin, aprotinin, and 
pepstatin A, and incubated on ice for 5 minutes. Samples were transferred to a glass 
tissue homogenizer and homogenized for 5 rounds. The samples were centrifuged at 720 
rpm for 2 minutes at 4°C. The supernatant was removed and the pellet was resuspended 
in 1 ml of CE buffer containing protease inhibitors and spun at 720 rpm for 2 minutes at 
4°C. Supernatant was removed and the pellet was resuspended in 1 ml SDS lysis buffer 
with 5 µg/µl of each leupeptin, aprotinin, and pepstatin A and incubated on ice for 30 
minutes. The sample was then treated to an additional 5 rounds with the tissue 
homogenizer. Samples were split into volumes of 200-300 µl per tube to be sonicated as 
stated below.  
 
Chromatin Sonication and Sonication Check 
  Chromatin samples were sonicated 13 times on level 4 for 10 seconds using the 
Fisher Scientific Sonic Dismembrator Model 100. Tubes were centrifuged at 13000 rpm 
for 10 minutes at 4°C and combined into one new tube and 15-20 µL was aliquoted to 
check the sonication and the remainder was placed into the -80°C freezer. To check the 
sonication 80 µl of dH2O and 6 µl of 5 M NaCl were added to the chromatin sample for 
reverse crosslinking and incubated in a heating block at 65°C overnight. Samples were 
removed from the heating block and when they reached room temperature, 2 µL of 10 
µg/µl proteinase K was added and samples were incubated for 1 to 2 hours at 42°C. 
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Phenol chloroform extraction was then performed and RNAse was added to samples for 
30 minutes at room temperature. Samples were then run on a 1% agarose (Fisher 
Scientific, Fair Lawn NJ) gel and visualized using the UVP BioDoc-ITTM System. 
 
2.2.4 Chromatin Immunoprecipitation (ChIP) 
  Information for all buffers used in this protocol is found in Appendix 6.1. 
Each ChIP reaction used 40 µg of chromatin, isolated as stated above. Samples were 
diluted to a concentration of 400 ng/µL at a volume of 100 µL for each antibody ChIP 
reaction, using lysis buffer containing protease inhibitors. Lysis buffer and chromatin 
solution was diluted with 300 µL of dilution buffer to give a final volume of 400 µL per 
antibody reaction. Protein A agarose (Millipore, Temecula CA) or magnetic beads were 
used. Agarose beads were washed twice using 500 µL of PBS and given a final wash 
with 300 µL of dilution buffer. When agarose beads were used samples were pre-cleared 
with 35 µL of beads for 1½ to 2 hours on a rotator at 4°C. The chromatin sample solution 
was centrifuged at 6000 rpm for 1 minute at 4°C and the supernatant collected. An 
aliquot 30 µL of chromatin sample solution was used for the input control. Antibody was 
added to each sample except input and samples placed on the rotator for 12-18 hours at 
4°C. Antibodies used included anti-Histone 3 (H3) tri-methyl K36 antibody (H3K36Me3; 
Abcam, Cambridge MA), Anti-RNA polymerase II (Millipore, Temecula CA), Anti-
H3K4Me3, and Anti-H3K27Me3.  The antibody sample was mixed with 35 µL of 
prewashed agarose beads or 17 µL of magnetic beads and placed on the rotator for 1 hour 
at 4°C.  After 1 hour, the bead solution was centrifuged down for 1 minute at 6000 rpm 
for 1 minute at 4°C and supernatant was removed using a magnet to retain magnetic 
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beads. Beads were successively washed with 1 mL of a low salt wash buffer, a high salt 
wash buffer, a Lithium Chloride buffer and twice with a Tris-EDTA buffer pH 8.1 . For 
each wash beads were placed on the rotator for 10 minutes at 4°C followed by 
centrifugation at 6000 rpm for 1 minute at 4°C, and then supernatant was removed. Beads 
were placed on the rotator for 15 minutes at room temperature with 75 µL of elution 
buffer and then centrifuged at 6000 rpm for 1 minute. The supernatant was collected and 
the process repeated. Input samples had 150 µL of elution buffer added. Samples of 
chromatin and elution buffer has 6 µL of 5 M NaCl added, and placed at 65°C for 4 to 18 
hours. Following incubation, 1 µL of 10 µg/µl RNAse A was added and tubes placed at 
37°C for 30 minutes. 10 µL of EDTA-Tris HCl-Proteinase K solution was then added to 
each sample. Samples were placed at 45°C for 1 hour. Chromatin was isolated using the 
Wizard® SV Gel and PCR Clean-Up System (Promega, Madison WI).  
 
1.11 Primer Design, PCR, and qPCR 
 
Primer Design 
  All primers were designed using sequences from the University of California 
Santa Cruz (UCSC) Genome Browser and were generated by Sigma (Oakville, ON). 
Primer3 (Whitehead Institute and Howard Hughes Medical Institute) was used for 
choosing primer sequences from the UCSC Genome browser sequences. Primers for 
Atp2c2 mouse gene were designed based on the UCSC Genome browser identification 




Polymerase Chain Reaction (PCR) 
  Polymerase chain reaction (PCR) was carried out using a Bio Rad T100TM 
Thermal Cycler with 1 µl of cDNA or ChIP sample added to the master mix solution 
containing 10X Dream Taq Green Buffer (Promega, Madison, WI), 0.5 mM dNTP, 0.8 
pM forward and reverse primers, diluted in dH2O to a final volume of 23.85 µL per 
reaction. Samples were placed at 95°C and 0.15 µl of DreamTaq DNA Polymerase 
(Promega, Madison, WI) enzyme was added to each reaction. Products were amplified 
through 40 cycles, with each consisting of a melting step at 95°C for 30 seconds, 
annealing at 55-62°C for 30 seconds, and an elongation step at 72°C for 30 seconds. An 
additional elongation step of 72°C for 5 minutes was included in the final cycle. 
Temperature gradients were performed for each primer set to determine the optimal 
annealing temperature. All samples were resolved on a 1% agarose gel and visualized. 
 
Quantitative ChIP Polymerase Chain Reaction 
  All ChIP qPCR experiments were performed following manufacturer’s directions 
using the ViiATM 7 Real Time PCR System (Life Technologies) with the GoTaq® qPCR 
Master Mix (Promega, Madison WI). All reactions were performed in triplicate and 
contained 1 µl ChIP sample, 5 µl GoTaq® qPCR Master Mix containing Sybr green, 0.30 
µM of forward and reverse primers, 2.5 mM dNTPs, and diluted to a final volume of 10 
µL with nuclease-free water. Products were amplified through 40 cycles, with each 
consisting of a melting step at 95°C, annealing at 60°C, and an elongation step at 72°C, 
each for 30 seconds. Signal was recorded during the annealing step and a melting curve 
was also generated. Data was analyzed using the Viia7 Ruo software (Life Technologies). 
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Temperature gradients were performed for each primer set to determine optimal 
annealing temperature using PCR.  
 
1.12 Bioinformatics 
  All Encyclopedia of DNA Elements (ENCODE) RNA-Sequencing and ChIP-
Sequencing data was analyzed using the UCSC Genome browser 
(http://genome.ucsc.edu/encode/). 
Protein sequences were predicted using the National Center for Biotechnology 
Information (NCBI) Open Reading Frame finder  
(http://www.ncbi.nlm.nih.gov/gorf/gorf.html). Protein structure was predicted using the 
European Molecular Biology Laboratory (EMBL)- European Bioinformatics Institute 
(EBI) InterProScan 4 program (http://www.ebi.ac.uk/Tools/pfa/iprscan/). 
 
1.13 Cell Culture 
  Cell lines including the rat pancreatic acinar cell line AR42J (ATCC, Manassas 
VA), and Human embryonic kidney 293 adherent (HEK293A) cell line were maintained 
in an incubator at 37°C with 5% CO2 and 95% O2. AR42J cells were maintained in F12 
Kaighn’s Modification (F12-K) media (Gibco, Grand Island NY) containing 1% 
penicillin (1000 units/mL) Streptomycin (1000 units/mL) (Penstrep) (HyClone, Logan 
UT) and 20% fetal bovine serum (FBS) (Fisher Scientific, Ottawa ON). HEK293A cells 
were maintained in 1X Dulbecco’s Modified Eagle Medium (DMEM) high glucose 
media (HyClone, Logan UT) containing 10% FBS and 1% Penstrep. Media was changed 
every two days and cells expanded using 0.25% w/v trypsin (HyClone, Logan UT) when 
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the cells reached 60-70% confluency in a T-75 flask (BD Falcon, Mississauga, ON). For 
immunofluorescence cells were grown on coverslips (Fisher Scientific, Ottawa ON) 
coated with 1mg/mL Poly-L-lysine (Sigma, St. Louis MO) and for RNA isolation cells 
were grown in 60 mm dishes (Corning, Big Flats NY).  
 
1.14 Transfections and Construct Design  
 
Construct Design 
  Constructs pMK−2286/+1544 ATG-FLAG-SPCA2-c, pGL3−1238 ATG 24-
Promoter, pGL3−619 ATG 24-Promoter, pGL3−309 ATG 24-Promoter, and pGL3-
Alternate −1238 ATG 23-Promoter, were designed based on the UCSC Genome browser 
identification Atp2c2 (uc009nqg.1) and were constructed by Invitrogen GeneArt® 
(Regensburg, Germany).  For all sequences see Appendix 6.3-6.7. 
 
FuGENE Transfections 
  Transfections were performed on HEK293A and AR42J cells at 70-80% 
confluency in 6-well plates for immunofluorescence (IF), 24-well plates for luciferase 
assays, and 60 mm plates for RNA isolation.  Cells used for  IF, RNA and protein 
isolation were transfected  with pcDNA3.0-Green Fluorescent Protein (GFP)  or 
pcDNA3.0-MIST1-VP16-HA or pcDNA3.0-FLAG-SPCA2916-1077 or pMK−2286/+1544 
ATG-FLAG-SPCA2-c, or  pMK−2286/+1544 ATG-FLAG-SPCA2-c and pcDNA3.0-
MIST1-VP16-HA. Cells used for luciferase protein isolation were transfected with pRL-
SV40 and one of  pGL3−1238 ATG 24-Promoter, pGL3−619 ATG 24-Promoter, 
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pGL3−309 ATG 24-Promoter, or pGL3-Alternate −1238 ATG 23-Promoter, in addition 
to either pcDNA3.0-Green Fluorescent Protein (GFP)  or pcDNA3.0-MIST1-VP16-HA. 
For 6-well plates, a total of 2 µg of DNA was added per well in a 100 µL solution of 
serum free media, with 7 µL of FuGENE transfection reagent (Promega, Madison WI). 
The media/FuGENE solution vortexed, and allowed to form a transfection complex for 
15 minutes at room temperature while 2 mL of fresh media was added to each well. The 
transfection complex was gently agitated and added to each well in a drop wise manner. 
For 60 mm plates a total of 4 µg of DNA was added per plate in a 200 µL solution of 
serum free media with 14 µL of FuGENE transfection reagent. RNA was isolated, protein 
was isolator cells were fixed for immunofluorescence 48 hours after transfection.  
 
1.15 Immunofluorescence  
  Cells were seeded on 6-well plates (BD Falcon, Mississauga ON) with cover slips 
at a density of 70% or higher and fixed two days later for IF. Cell lines were washed 
twice with 1x PBS (Hyclone, Logan UT) and fixed in the 6-well dish with cover slip with 
4% formaldehyde for 20 minutes on ice. After fixation samples were washed 3x5 minutes 
in PBS. Samples were permeabilized with 0.1% Triton X-100 (BDH, Mississauga ON) in 
PBS for 10 minutes followed by a 1-2 hour incubation in 5% Bovine Serum Albumin 
(BSA) (EMD Sciences, Gainsburg, NJ) + 0.1% Triton X-100 in PBS (blocking solution). 
Samples were incubated with primary antibody diluted with blocking solution. The 
primary antibodies used included mouse anti-FLAG (1:500, Sigma), rat-anti-HA (1:500, 
Roche), anti-rabbit MIST1 (ProSci Inc.), and rabbit anti-SPCA2 (1:500, ProSci Inc.). 
Following a 1 hour incubation at room temperature, samples were washed 3x5 minutes 
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with PBS and then incubated for 1 hour at room temperature with secondary antibodies, 
including fluorescein isothiocyanate (FITC) goat anti-rat IgG (Jackson Immunoresearch 
Labs, West Grove, PA), FITC goat anti-rabbit IgG, tetramethylrhodamine isothiocyanate 
(TRITC) goat anti-rabbit IgG, and TRITC goat anti-mouse IgG (Sigma).  Samples were 
washed with PBS 3x5 minutes and incubated with 4,6 diamidino-2-phenylindole 
dihydrochloride hydrate (DAPI) in PBS (1:1000, Sigma) for 10 minutes.  
 
1.16 RNA Isolation 
  RNA was isolated from AR42J and HEK293A cell lines. Cells were washed twice 
with PBS.  1 mL ice cold Isol RNA Lysis Reagent (5prime, Gaithersburh MD) was added 
and cells were homogenized by pipetting up an down and using a cell scraper. Samples 
were left on ice for 5 minutes. 200 µL of chloroform was added, each sample was shaken 
vigorously for 15 seconds and left on ice for 3 minutes. After incubation, the samples 
were centrifuged at 5000 rpm for 15 minutes at 4°C. The aqueous phase (containing 
RNA) was transferred to a new tube and precipitated using 500 µL of isopropanol. 
Samples were placed at -20°C overnight and then centrifuged at 5000 rpm for 15 minutes 
at 4°C. The resulting pellet was washed with 1 mL of 75% ethanol. Once the pellet was 
dislodged, the samples were centrifuged at 5000 rpm for 10 minutes at 4°C. The 
supernatant was removed and the pellet air dried for approximately 10 minutes. RNA was 




1.17 Protein Isolation and Western Blot Analysis 
   Protein was isolated from AR42J and HEK293A cells. Cells were washed twice 
with cold PBS. Cells were scraped into an isolation buffer containing 50mM Tris (pH 
7.2), 5 mM MgCl2, 1mM CaCl2, 10 mM dithiothreitol (DTT), 1% NP-40, 100 units/ml 
DNAse 1, 50 µg/ml RNAse A, 30mM sodium fluoride, 20mMsodium orthovandate, 10 
mM sodium molybdate, 75 ug/ml PMSF and 5µg/ml of each leupeptin, pepstatin, and 
chymostatin. Cells were collected using a cell scraper, sonicated for 15 seconds, and 
centrifuges at 6000 rpm for 5 minutes at 4°C. The supernatant was transferred to a new 
tube and the pellet discarded.  
  For Western blot analysis, 10-50 µg of protein was added to the sample buffer 
containing 1% β-mercaptoethanol and bromophenol blue and boiled at 95°C for 5 
minutes. Samples were resolved at 100 volts on a 12% SDS polyacrylamide gel (PAGE) 
until the dye front ran off the bottom of the gel. The protein was transferred to a 
polyvinylidene difluoride (PVDF) membrane (BioRad, Hercules CA) at 200mA for 90 
minutes. Following the transfer, the PDVF membranes were incubated in blocking 
solution consisting of 5% non-fat dried milk (NFDM) in Tris buffered saline (TBS) with 
0.1% Tween-20 (TBS-T) for 1-2 hours at room temperature. Membranes were incubated 
with primary antibodies overnight at 4°C with mild rocking. Primary antibodies used 
included rabbit anti-SPCA2 (1:250) and rabbit anti-MIST1 (1:1000) diluted in blocking 
solution. Following incubation, PVDF membranes were washed 5x5 minutes with TBS-T 
and incubated in horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (1:10000, 
Jackson Immunoresearch Labs, West Grove PA) diluted in blocking solution for 1 hour at 
room temperature. Membranes were then washed 6x5 minutes with TBS-T and 
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chemiluminescent substrate (PerkinElmer, Boston MA) was added to the blots according 
to the protocol provided by the manufacturer. Membranes were developed using the 
VersaDoc (BioRad, Hercules CA). 
   
1.18 Luciferase Assay  
  Protein was isolated using the Dual-Luciferase® Reporter Assay Kit (Promega, 
Madison WI). Transfections were performed in triplicate and each 20 second triplicate 
read was performed in triplicate using the Lumat LB 9507 Luminometer (Berthold 
Technologies, Oakridge TN). Firefly luciferase reads were normalized using renilla 
luciferase reads, and this ratio was normalized to the ratio for the negative control pGL3-
Basic. Data was analyzed using GraphPad Prism software version 6.0 by two way 
analysis of variance (ANOVA) with a Bonferroni post hoc test. All graphs show mean 

































 	  	  	  	  	  	  	  















1.19 Identification of Atp2c2c Transcriptional Start Site  
 
Bioinformatic analysis suggests Atp2c2c differs between human and mouse 
  Bioinformatic analyses of the ENCODE data was conducted to explore ATP2C2 
RNA transcripts using the RNA- Sequencing (RNA-Seq) data. Bioinformatics analysis of 
the ENCODE RNA-Seq suggests that the ATP2C2 is transcribed from a unique TSS or 
alternative splicing. Through analysis of the ENCODE RNA-Seq data, it appears that in 
human there is an ATP2C2 isoform that begins in the intronic region between exon 24 
and 25. The first exon of this human ATP2C2c isoform includes most of the 24th  intron 
and the 24th exon of the longer ATP2C2 isoform, a similar transcript has not been 
identified in mice [Figure 3.1 A]. Alignment between the human SPCA2c predicted 
protein sequence with the protein sequences of SPCA2 from human, mouse, rat, and dog 
were compared. The	  predicted	  ATG	  initiating	  codon	  in	  the	  human	  transcript	  is	  in	  frame	  with	  the	  carboxy	  terminus	  of	  the	  full-­‐length	  protein.	  	  In	  other	  words,	  if	  this	  is	  a	  novel	  TSS,	  it	  still	  encodes	  a	  truncated	  SPCA2,	  not	  a	  completely	  new	  protein	  [Figure 
3.1 B]. 
  Mouse bioinformatics data does not include a transcript that starts at the same place 
as the transcript identified in human. However if a TSS were in a similar area, the 
initiating ATG would be in frame with the full-length protein. Using EBI Open Reading 
Frame finder a transcript corresponding to the sequence originating from the ATG found 
in exon 24 was predicted in mouse. Protein structure was predicted for the mouse and 
human truncated isoforms using the European Bioinformatics Institute-Interpro Scan 
program and the human protein was predicted to be approximately 28 kDa while the 
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mouse protein was predicted to be approximately 15 kDa. The proteins also showed 
highly similar predicted structure with both proteins containing a Ca2+ ATPase domain 
and a signal peptide, suggesting they may localize to a membrane. The human protein 
contains 4 predicted transmembrane domains while that of the mouse contains only 2 
transmembrane domains, though the mouse signal peptide domain appears to line up with 
the transmembrane domain 2 in the human protein [Figure 3.1 C and D].   
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Human   M E L C V V G L T G W S S F T V C G T D G G A Q L P !
!
Human   M D P G S G A S G R C R G G Q V R C L G A F S K C L  !
!
Human   A L P P V P T W P G R L R H S C F K G P L F H S W F !
!
! ! ! ! ! !  !                   *!
Human   I S K C L C L V R S S L G V E P V D K D A F R Q P P !
HumanL                      S L G V E P V D K D A F R Q P P !
Rat                         S L G V E P V D R D A L K R P P!
Mouse                       S L G V E P V D R D A L R R P P!
Dog                         A C L G V E P V D K D T L Q Q P !
!
        *       * * * *   *   * * *     *   * * *   *     * !
Human   R S V R D T I L S R A L I L K I L M S A A I I I S G !
HumanL  R S V R D T I L S R A L I L K I L M S A A I I I S G !
Rat     R S V K D T I L N R A L I L K I L M S A A V I L G G!
Mouse   R S V G D T I L N R A L I L R V L M S A A V I I G G !
Dog     R N I R D T I L S R S L I L K I L L S A A V I I S G!
!
!   * * * * * *   *   *         * * * * * * * *   * * * !
Human   T L F I F W K E M P E D R A S T P R T T T M T F T C !
HumanL  T L F I F W K E M P E D R A S T P R T T T M T F T C!
Rat     T L F I F W R E I P E N R T S T P R T T T M A F T C!
Mouse   T L F I F W R E I P A N G T S T P R T T T M A F T C!
Dog     T L F I F W K E I P A D K A S T P R T T T M T F T C!
!
        * * * * * * * * * *   * * * * * * * * * * * * *   * !
Human   F V F F D L F N A L T C R S Q T K L I F E I G F L R !
HumanL  F V F F D L F N A L T C R S Q T K L I F E I G F L R!
Rat     F V F F D L F N A L S C R S Q T K L I F E I G F F R!
Mouse   F V F F D L F N A L S C R S Q T K L I F E I G F F R!
Dog     F V F F D L F N A L T C R S Q T K L I F E I G F L R!
!
   !
!*   * * * * *   * * *   * * * * * * * *   * * * * !
Human   N H M F L Y S V L G S I L G Q L A V I Y I P P L Q R !
HumanL  N H M F L Y S V L G S I L G Q L A V I Y I P P L Q R!
Rat     N R M F L Y S I L G S L L G Q L A V I Y A P P L Q K !
Mouse   N R M F L Y S V L G S L L G Q L A V I Y A P P L Q K!
Dog     N P M F L Y S V L G S I L G Q L A V I Y V P P L Q K!
!
!   * * * * * * *   * * * * *   * * * * * * * * * * * * !
Human   V F Q T E N L G A L D L L F L T G L A S S V F I L S !
HumanL  V F Q T E N L G A L D L L F L T G L A S S V F I L S!
Rat     V F Q T E N L S A L D L L L L T G L A S S V F I L S!
Mouse   V F Q T E N L S A L D L L L L T G L A S S V F I L S!
Dog     V F Q T E N L G A L D L L F L T G L A S S V F I L S!
!
        * * * * *   * *                 *           * !
Human   E L L K L C E K Y C C S P K R V Q M H P E D V!
HumanL  E L L K L C E K Y C C S P K R V Q M H P E D V  !
Rat     E L L K L C E K F C S R A K A D Q M L P E A V!
Mouse   E L L K L W E K F L S R A R P T Q M L P E A V!








Figure. Human and Mouse SPCA2-c protein domains predicted using European 
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Figure	  3.1	  Atp2c2	  gene	  and	  Secretory	  Pathway	  Ca2+	  ATPase	  protein	  	  
(A)	  Atp2c2	  gene	  schematic,	  exons	  in	  black	  and	  introns	  in	  grey.	  (B)	  Atp2c2	  truncated	  carboxy	  gene	  (Atp2c2c)	  (C)SPCA2	  protein	  structure	  in	  mouse.	  Cation	  binding	  site	  in	  green,	  cation	  ATPase	  domain	  in	  purple,	  hydrolase	  domain	  in	  blue,	  and	  transmembrane	  domains	  in	  black.	  (D)	  Truncated	  SPCA2	  carboxy	  protein	  (SPCA2c).	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Histone modifications of Atp2c2 indicate a Novel Transcriptional Start Site  
 
  The bioinformatics data suggest that a novel transcriptional start site exists within 
the 23rd intron of Atp2c2. To investigate this possibility in more detail, ChIP was 
performed on isolated murine acinar cells for H3K4Me3 (active TSS) and H3K27Me3 
(repressive) using primers for specific to the full length Atp2c2 (L) and the 23rd intron 
(III) in wild type and Mist1-/- mice. H3K4Me3 and H3K27Me3 enrichment was examined 
in Mist1-/- tissue to look for modifications affecting gene expression because SPCA2 is 
not expressed. The region upstream of the full length Atp2c2 (L) gene shows limited 
expression in wild-type or Mist1-/- animal pancreatic acinar cells, and no enrichment of 
either H3K4Me3 or H3K27Me3. Conversely, H3K4Me3 enrichment was observed only 
in the genomic region corresponding to the intron 23 in pancreatic acinar cells of wild 
type animals by ChIP-PCR [Figure 3.2].   Consistent with the loss of Atp2c2c expression 
in Mist1-/- animals, no H3K4Me3 enrichment was observed in intron 23. Enrichment of 
H3K27Me3 was not observed around the Atp2c2 gene in wild type mice but was 
observed in Mist1-/- chromatin in the region of intron 23, suggesting that gene silencing of 
Atp2c2 occurred in these mice. These observations were supported by ChIP analysis 
followed by Next Generation Sequencing, which revealed little enrichment of H3K4Me3 
in the region of exon 1 in both Mist1-/- and wild type mice, but a robust enrichment of 
H3K4Me3 in the area of exon 24 only in wild type tissue. Again, in Mist1-/- mice the 
increase in enrichment for H3K27Me3 and decreased H3K4Me3 at this region suggests 
gene silencing. Combined these results suggests that there is a TSS just 5' of exon 24 in 
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the Atp2c2 gene in pancreatic acinar cells [Figure 3.2 A]. More in depth analysis of the 
ENCODE ChIP-Seq data indicated that the H3K4Me3 enrichment observed in pancreatic 
acinar cells of wild type mice appears to be restricted to a few cell types. H3K4Me3 and 
H3K36Me3 enrichment were not observed in human heart, liver or cerebellum [Figure 
3.3 A]. Interestingly, enrichment of H3K4Me3 was observed in erythroblasts and 
megakaryocytes even though the peak was shifted slightly downstream to the region of 
intron 25. [Figure 3.3 B].  Combined these results suggests that there is a TSS just 5' of 
exon 24 in the Atp2c2 gene in pancreatic acinar cells. However, the presence of 




































































Figure	  3.2.	  H3K4Me3	  and	  H3K27Me3	  enrichment	  on	  Atp2c2	  in	  pancreatic	  acinar	  cells.	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Figure	  3.3.	  Truncated	  Atp2c2c	  appears	  to	  be	  pancreas	  specific.	  
	  	  
(A)	  H3K4Me3	  and	  H3K36Me3	  enrichment	  from	  ChIP-­‐Seq	  on	  pancreatic	  acinar	  cells,	  erythroblasts,	  megakaryocytes,	  liver,	  heart	  and	  cerebellum.	  (B)	  Zoom	  to	  show	  enrichment	  for	  H3K4Me3	  only	  observed	  at	  the	  24	  exon	  and	  24	  intron	  in	  pancreas.	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Histone modifications define the TSS of Atp2c2c downstream of exon 24 
  To further validate whether the genomic region around exon 24 of the Atp2c2 
gene represents a novel TSS, other epigenetic modifications specific to TSSs were 
examined. ChIP was performed on whole pancreas of 4 to 5 month old C57Bl6 male 
mice for histone modifications H3Ac, and H3K36Me3. Enrichment for modifications was 
observed in the upstream region of gene corresponding to a TSS located downstream of 
exon 24, this verified what was seen in the ChIP-Seq [Figure 3.4]. Enrichment of 
H3K4Me3 and H3Ac were observed most robustly in the area of intron 23 to exon 26 
[Figure 3.4 D-E]. Enrichment of H3K36Me3 was observed beginning at intron 24 and 
continuing down the gene [Figure 3.4 C]. ChIP-PCR and qPCR for Mist1 and RNA Pol 
II was performed from whole pancreas as described above. Mist1 binding to the Atp2c2c 
gene was observed in the area of intron 24, suggesting that Mist1 may regulate Atp2c2c 
expression in the pancreas. Additionally RNA Pol II enrichment was observed in the area 
of intron 24 suggesting this is a TSS and that general transcriptional machinery is being 
recruited to this region of the gene [Figure 3.5]. E-box consensus sites (CAGCTG) 
where Mist1 would bind are found three times in intron 24, supporting the ChIP data 
showing Mist1 binding in this region [Figure 3.5 C]. The location of these epigenetic 
modifications, in combination with the ChIP-Seq data suggests there is a novel TSS for 
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Figure	  3.4.	  Analyses	  of	  pancreatic	  Atp2c2	  epigenetic	  modifications	  suggesting	  a	  novel	  TSS	  
in	  region	  of	  Exon	  24.	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Figure	  3.5.	  Enrichment	  of	  RNA	  Polymerase	  II	  and	  MIST1.	  	  
(A)	  ChIP	  PCR	  with	  primer	  set	  III	  shows	  enrichment	  for	  	  RNA	  Pol	  II	  and	  MIST1	  (B)	  ChIP	  qPCR	  for	  RNA	  Pol	  II	  and	  MIST1	  shows	  enrichment	  in	  the	  area	  54kb	  downstream	  of	  the	  pre-­‐established	  TSS	  suggesting	  a	  novel	  TSS	  (C)	  Schematic	  of	  the	  Atp2c2	  gene	  in	  the	  region	  enriched	  for	  MIST1,	  with	  arrows	  indicating	  E-­‐box	  consensus	  sites	  for	  MIST1	  binding,	  red	  arrows	  indicate	  CAGCTG	  E-­‐boxes	  which	  has	  been	  shown	  to	  be	  MIST1	  preferred.	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1.20 Expression of Spca2c 
 
Expression of Atp2c2c in vitro 
  To investigate whether the region around exon 24 represents a novel TSS I assessed 
the ability of the region to drive expression. I approached this in two ways.  The first was 
to generate a construct containing a 2286 bp region upstream of the putative ATG 
initiation codon located in exon 24, which encompasses a potential promoter, and place 
this upstream of exons 24 to 27 with introns removed. The resulting construct 
(pMK−2286/+1544 ATG-FLAG-SPCA2c) also places a FLAG antigenic tag just before 
the stop codon  [Figure 3.6 A]. pMK−2286/+1544 ATG-FLAG-SPCA2c was transfected 
into AR42J (acinar-like) and HEK293A (non-acinar) cells alone or co-transfected with 
pcDNA3.0-MIST1-VP16-HA,which contains the VP16 transcriptional activation domain 
allowing Mist1 to bind to and activate transcriptional complexes. Expression of SPCA2c 
was observed in AR42J cells when transfected alone or with enhanced MIST1 
accumulation [Figure 3.6 B].  Unexpectedly, similar transfections in HEK293A resulted 
in SPCA2 accumulation, with expression of SPCA2 slightly increased in the presence of 
MIST1 [Figure 3.6 C].  Analyses of SPCA2 expression by Western blot in AR42J cells 
showed expression of Spca2 in the 17 to 20 kDa size expected. Expression of this protein 
appeared to increase slightly with  pMK−2286/+1544 ATG-FLAG-SPCA2c compared to 
untransfected and pcDNA3.0-GFP transfected cells.   No shift was observed in the size of 
this protein suggesting that this construct was resulting in expression of a similar Spca2 
to that expressed in the acinar cell endogenously. This protein was identified with and 
without Mist1 overexpression [Figure 3.6 D]. The IF and protein expression both suggest 
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that the region upstream of ATG contains a TSS and that this region has promoter 
activity allowing it to express a protein that is the correct size and recognized by a 










































































































































































Figure 3.6. Expression of -2286/+1544 ATG FLAG SPCA2c. 
   
(A) -2286/+1544 ATG SPCA2c FLAG construct schematic.  IF of cells untransfected or transfected 
with: pMK -2286/+1544-AT- FLAG-SPCA2c (SPCA2c), pcDNA3.0-MIST1-VP16-HA (Mist1), or both 
pMK -2286/+1544-AT- FLAG-SPCA2c and pcDNA3.0-MIST1-VP16-HA for expression of SPCA2c 
and Mist1 (green) and merged with DAPI in (B) AR42J cells (scale bar = 25 µm) and (C) HEK293A 
cells (scale bar = 25 µm) (D) Western blot for SPCA2 and Mist1 and Actin (loading control) on AR42J 




The Atp2c2c promoter is located downstream of exon 24 ATG 
  The second approach to validating this novel Atp2c2 TSS was to generate 
constructs in which the genomic regions upstream of the putative ATG initiation codon 
were placed in front of luciferase reporter genes.  Constructs were designed to contain 
decreasing lengths of sequence upstream of the ATG in exon 24 to identify regions of the 
promoter that may contain important regulatory elements. Constructs were named 
according to the length of sequence they contained upstream of the ATG in exon 24 and 
as a control a similar construct containing sequence found upstream of an ATG located in 
exon 23 was also designed. The following constructs were created:  pGL3−1238 ATG 24-
Promoter, pGL3−619 ATG 24-Promoter, pGL3−309 ATG 24-Promoter, and pGL3-
Alternate −1238 ATG 23-Promoter  [Figure 3.8]. In non-acinar HEK293 cells, construct 
pGL3−619 ATG 24-Promoter shows the greatest luciferase activity in the presence of 
Mist1. This demonstrates that this sequence has the strongest promoter activity and that 
Mist1 plays a role in activating expression since it displays significantly greater 
expression than all of the other constructs and significantly greater expression in the 
presence of Mist1 compared to its absence [Figure 3.9 A]. 
  All of the constructs containing sequence upstream of ATG in exon 24 showed 
luciferase activity. HEK293A cells show greater luciferase expression overall, likely due 
their better transfection efficiency. In HEK293A cells pGL3−619 ATG 24-Promoter and 
pGL3−309 ATG 24-Promoter show the greatest luciferase expression compared to the 
other constructs. However these constructs do not differ significantly from one another 
suggesting they both have strong promoter ability. The addition of Mist1 to these 
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constructs expression also appears to have no significant effect on expression. 
Interestingly the pGL3-Alternate −1238 ATG 23-Promoter has significantly decreased 
promoter activity compared to both the -619 and -309 constructs, and even significantly 
lower expression than the negative control pGL3-Basic, suggesting that perhaps this 
region may contain a repressor domain [Figure 3.9 B]. In AR42J cells none of the 
constructs showed significant expression compared to the negative control. However in 
the presence of Mist1 construct pGL3−619 ATG 24-Promoter luciferase expression was 
significantly higher than control and all other constructs in both with and without Mist1 
[Figure 3.9 C]. These results suggest that the region upstream (51) of exon 24 shows 
promoter activity in AR42J and HEK293A cells, and in AR42J cells the addition of 
Mist1 may enhance activity.  
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Figure 3.7. Relative Luciferase Expression of Atp2c2c promoter constructs. 
  
 (A) Gene Schematic showing regions contained in luciferase ATG promoter constructs. Construct 
numbering refers to base pair position relative to the ATG in exon 24. Alternate ATG promoter 
contains 1238 base pair region upstream of the ATG located in exon 23.    
Luciferase promoter activity of constructs in (B) AR42J cells  and (C) HEK293A cells. Luciferase 
expression is a measure of firefly luciferase normalized to renilla luciferase expression, this ratio is 
then normalized to the negative control pGL3-Basic luciferase expression.  
* P≤ 0.05, ** P≤ 0.01, ***  P≤0.001 
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1.21 Brief Summary of Conclusions 
The experiments conducted in this thesis came to four specific conclusions: 
 
1. Identification of a novel transcriptional start site for Atp2c2 in mice. 2. This	  transcriptional	  start	  site	  for	  Atp2c2c	  is	  limited	  to	  a	  subset	  of	  tissues.	  3. Determined	  that	  619	  bp	  is	  required	  for	  at	  least	  some	  expression	  from	  this	  TSS.	  4. MIST1	  binds	  to	  the	  Atp2c2c	  gene	  near	  to	  this	  novel	  TSS	  in	  pancreatic	  tissue.	  	  In	  its	  absence,	  the	  Atp2c2	  gene	  becomes	  enriched	  for	  silencing	  marks.	  
 
1.22 Summary  
  Pancreatic acinar cells must highly regulate Ca2+ levels to allow for proper 
secretion of digestive enzymes. They control Ca2+ levels through store operated Ca2+and 
Ca2+ ATPases. This thesis describes the identification of a novel TSS for Atp2c2 and 
identification of MIST1 as a regulator of Atp2c2c expression in pancreatic acinar cells. 
Bioinformatics analyses identified a potential difference between human and mouse 
Atp2c2c and subsequently predicted SPCA2c. Bioinformatics analysis also suggests that 
expression of Atp2c2c is restricted to pancreas, with the possible exception of 
megakaryocytes and erythroblasts. The TSS of this isoform was also identified as being 
in the area of exon 24 by enrichment of histone marks indicating transcriptional 
activation. This region was further confirmed to have promoter activity through luciferase 
assays and MIST1 was shown to enhance promoter activation in vitro. ChIP also 
confirmed that MIST1 was binding to the Atp2c2 gene in the region of the novel TSS, in 
addition to RNA Pol II binding. This strongly suggests there is transcriptional activity of 
this region. Therefore Atp2c2c is a novel isoform of Atp2c2, which, may be regulated by 
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MIST1. Understanding the transcriptional regulation of this gene is important for 
defining the full length of Spca2c and understanding how Spca2c expression is altered 
during pancreatitis.  Additionally understanding how Atp2c2 is transcriptionally regulated 
in the pancreas allows it to be targeted for ablation. The ablation of Atp2c2c will provide 
insight into whether aspects of the Mist1-/- phenotype result from the loss of Atp2c2c. In 
particular the dysfunction in regulating cytoplasmic Ca2+ levels and disruptions in 
regulated exocytosis might be the result of lost Atp2c2c expression, giving insight into its 
function and role in pancreatic pathology (Garside et al., 2010; Pin et al., 2001).  
  To date the Atp2c2 gene has not been targeted for ablation though it is being 
increasingly recognized as an important player in Ca2+ regulation of secretory cells, and 
as a potential contributor to pathological processes such as pancreatitis and tumorigenesis 
(Capoccia et al., 2011; Cross et al., 2013; M.-Y. Feng & Rao, 2013; M. Feng et al., 2011; 
Garside et al., 2010).   
 
1.23 Identification of a novel transcriptional start site for Atp2c2 in mice. 
  Previous experiments from our lab identified a truncated SPCA2c protein, which 
could be the result of either alternative splicing or an alternative TSS. By identifying 
histone modification patterns and luciferase promoter analysis Atp2c2c appears to be the 
result of a novel TSS. Enrichment of H3K4Me3, H3K36Me3 and H3Ac are all found in 
the area of the ATG located in exon 24 demonstrating that this region is likely a TSS, 
though transcriptional activity is not guaranteed by enrichment of these marks (Zentner & 
Henikoff, 2013).  Mist1 and RNA Pol II are also shown to bind in this region suggesting 
transcriptional machinery is being recruited to this area [Figure 4.1]. Mist1 binding in 
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this area was also observed by ChIP-Seq in mouse pancreas, which identified Mist1 
binding 54 kilo bases downstream of the full-length Atp2c2 TSS (Direnzo et al., 2012).  
  Additionally luciferase assays confirmed that the region upstream of the ATG in 
exon 24 demonstrates promoter activity in both AR42J and HEK293A cells. It is curious 
that this promoter was active in HEK293A cells, which would not be expected to express 
a pancreas specific gene. Though the HEK293A cells did not show increased activity in 
response to MIST1, suggesting the expression might be mediated by other factors in this 
cell line.  The construct pMK−2286/+1544 ATG-FLAG-SPCA2-c containing a 2286 bp 
region upstream of the ATG in exon 24 followed by the sequence of exons 24-27 was 
able to produce a protein of equal size to the endogenous protein. Unfortunately this 
protein could not be detected using the FLAG tag because the FLAG tag in the construct 
was designed to express as DYKDDDK for recognition by a discontinued Millipore 
antibody (Cat. # MAB3118, Lot # JC1629909). Currently available FLAG antibodies 
recognize the DYKDDDDK sequence and will not recognize the above sequence. This 
protein was recognized by SPCA2 antibody suggesting it is the same protein but in future 
experiments it would be of interest to modify the FLAG sequence in this construct so 
expression can be definitively attributed to expression of the construct. This supports the 
existence of TSS and an active promoter in this area. Identification of the promoter of 
Atp2c2c is important to delineate SPCA2 protein structure in the pancreas and to allow 
Atp2c2c to be targeted for ablation, so we can begin to elucidate its function.  
  H3K27Me3 enrichment on Atp2c2 was observed in Mist1-/- acinar cells, 
suggesting Atp2c2 is silenced in the absence of Mist1. Future experiments should include 
investigating whether other silencing marks such as H3K9Me3 are enriched in this area 
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as well (Rye et al., 2011). In addition to whether knock-down of MIST1 would cause 




























































































Figure	  4.1	  Overview	  of	  Atp2c2-­‐c	  Epigenetic	  Modifications,	  RNA	  Pol	  II,	  and	  MIST1	  
Enrichment.	  	   
	  	  
71	  
1.24 Atp2c2c expression in human 
   The carboxy terminus of SPCA2 appears to be quite highly conserved between 
species. An isoform similar to mouse Atp2c2c appears to be present in human but this 
isoform begins in the intronic region between exon 24 and 25. It is unlikely that the 
mouse isoform includes this intronic sequence because in the mouse genome there is no 
ATG codon that would give a functional protein. The addition of this intronic region 
results in a predicted protein that contains an additional 80 amino acids at the amino 
terminus in the human, which are not found in the mouse. Despite this difference in 
sequence the structure and protein domains found in mouse and human, SPCA2c appear 
to be highly similar, suggesting that these isoforms may share a similar function. Future 
experiments should aim to identify the expression of this transcript in human secretory 
tissues as this transcript was identified as part of an effort to identify novel secreted 
proteins in the human genome using cDNA libraries and has not been confirmed to 
produce a protein or to exist in vivo (Clark et al., 2003). Preliminary efforts were made in 
our laboratory to identify this transcript in human pancreas and in human H1 embryonic 
stem cells, but the results were inconclusive. Given recent findings for the role of SPCA2 
in lactating mammary gland I think investigating this tissue for ATP2C2 expression can 
provide additional information on ATP2C2 gene regulation (M.-Y. Feng & Rao, 2013; M. 
Feng et al., 2011). It is important to identify this ATP2C2 human transcript and 
investigate whether it produces a protein product and if so to determine its size, tissue 
expression, and cellular localization in order to understand the role it may play in Ca2+ 
regulation and pancreatic pathology. 
  Interestingly when sequence consensus was investigated, the sequence that 
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appears to differ the most among the species is that of the canine. In dogs the methionine 
(ATG) that is found in rat, human, and mouse is not conserved. This is of interest because 
dogs are particularly sensitive to pancreatitis. This leads to the hypothesis that SPCA2c 
may have a role that is protective against injury in pancreatic acinar tissue. Preliminary 
results in our laboratory also suggest that Atp2c2 expression is decreased during injury, 
though this remains to be definitively confirmed. Prolonged SPCA2 activity, also results 
in constitutively high cytoplasmic Ca2+ levels in breast cancer cells, promoting 
tumorigenesis and proliferation (M. Feng et al., 2011). These findings suggest that 
excessive activity by Spca2 is damaging. Considering these findings on the effects of 
over activity in addition to preliminary observations of the effects of reduced Atp2c2 
expression, it seems that Atp2c2 expression must be tightly regulated and maintained in 
the physiological range. Any deviation from this in either direction has pathological 
effects on the cells ability to maintain basal cytoplasmic Ca2+ levels leading to pathology 
such as tissue disorganization and increased proliferation (M.-Y. Feng & Rao, 2013; M. 
Feng et al., 2011; Garside et al., 2010). The requirement for strict regulation of Atp2c2 
expression would not be surprising, as it is well known that the cell must strictly control 
Ca2+ levels (Clapham, 2007).   
 
1.25 Atp2c2c expression is limited to a subset of tissues 
  Expression of Atp2c2 has been previously characterized as restricted to secretory 
tissues such as pancreas, lactating mammary gland, testes, and salivary glands (Garside et 
al., 2010). Though Atp2c2c expression has been observed only in pancreatic acinar cells 
thus far ENCODE ChIP-Seq data suggest that this isoform or a similar isoform may also 
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be expressed in human megakaryocytes and erythroblasts. While the ENCODE ChIP-Seq 
data available to date does not include data obtained from a cell type with high secretory 
function, it is interesting to note that megakaryocytes and erythroblasts have been shown 
to have some secretory function. They secrete cytokines, growth factors, and chemokines 
involved in regulating hematopoiesis (Majka, 2001). This suggests a role for Atp2c2c 
expression in megakaryocytes and erythroblasts because SPCA2c has been shown to play 
a role in regulating Ca2+ for secretion in the lactating mammary gland and likely in 
pancreatic acinar cells (Cross et al., 2013; Garside et al., 2010).   
   These findings suggest that SPCA2c expression may exist in other secretory cell 
types and enable cells with robust secretory function to regulate Ca2+ levels, though this 
requires further investigation. While the expression of SPCA2c has not been identified in 
cell types other than pancreatic acinar cells, this suggests SPCA2c expression should be 
explored in other cell types with secretory function.  
  It remains to be investigated whether SPCA2 functions similarly in different cell 
types. In the lactating mammary gland SPCA2 has been shown to interact the store 
operated Ca2+ channel Orai1 at the basolateral membrane, to mediate Ca2+ influx that is 
independent of Golgi and ER stores. In these mammary cells, SPCA2 is localized to the 
perinuclear region, similar to the localization of SPCA2 in pancreatic acinar cells. In the 
mammary gland however SPCA2 also shows some punctate localization to the plasma 
membrane. At the plasma membrane SPCA2 colocalizes with Orai1 to mediate Ca2+ 
influx but it appears that the full length SPCA2 is more effective in interacting with Orai1 
than is the SPCA2 carboxy terminus alone (Cross et al., 2013; M. Feng et al., 2011).        
Unpublished results from Feng and Rao however suggest that the carboxy terminus of 
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SPCA2 alone is able to interact effectively with Orai1 (M.-Y. Feng & Rao, 2013). Orai1 
has been shown to colocalize with STIM1 at the basal membrane in pancreatic acinar 
cells. However the majority of Orai1 found in acinar cells is located at the apical 
membrane and the role of Orai1 here is controversial. Hong et. al. found Orai1 and 
STIM1 localizing at the apical membrane while Dingsdale et. al. did not observe this 
interaction with STIM1 (Dingsdale et al., 2012; Hong et al., 2011).   These results 
suggest that SPCA2c could possibly interact with Orai1 if it is able to localize to the 
plasma membrane. Interestingly it has been shown that movement to the plasma 
membrane of both Orai1 and SPCA2, from the perinuclear or ER region, requires Orai1 
and SPCA2 interaction (Cross et al., 2013). It however remains to be elucidated whether 
Orai1 and SPCA2 interact in pancreatic acinar cells. Orai1 localization in pancreatic 
acinar cells suggests that if Orai1 and SPCA2 did interact it would likely be at the apical 
membrane where the bulk of Orai1 is localized, though this seems unlikely because 
SPCA2 is localized to the basolateral perinuclear region in acinar cells (Garside et al., 
2010). Additionally, it has been suggested that SOCE and SICE may coexist, so it is 
possible that at the basolateral membrane some Orai1 could be interacting with SPCA2 
and some with STIM1, allowing it to function in both a store operated dependent and 
independent manner to regulate Ca2+ levels (M.-Y. Feng & Rao, 2013). In conclusion 
whether SPCA2 colocalizes with Orai1 in the pancreas should be investigated, though 
this seems unlikely since SPCA2 is basolaterally located while Orai1 is largely apically 
located. It is possible that pancreatic SPCA2 could also interact with other channels to 
mediate Ca2+ levels and that its functions differs between pancreas and mammary gland. 




1.26 Mist1 regulates Atp2c2c expression  
  MIST1 is a bHLH TF expressed in secretory tissues. MIST1 is necessary for 
development of secretory cells, as it regulates expression of a set of genes necessary for 
secretory function(Capoccia et al., 2011; Pin et al., 2001). Mice carrying a targeted 
ablation of the Mist1 gene (Mist1-/-) show disorganization of pancreatic acinar tissue, 
disruptions in Ca2+ handling, and defects in regulated exocytosis. Previous work in our 
lab suggests that the disruptions in Ca2+ handling may be attributed to loss of SPCA2, as 
it is the only Ca2+ ATPase, which loses expression in the absence of Mist1. Interestingly 
the primary SPCA expressed in pancreas appears to be a novel isoform of the Atp2c2 
gene consisting of the 3' end of the gene, entitled Atp2c2c (Garside et al., 2010). In this 
thesis, through ChIP-qPCR and luciferase assays it has been shown that MIST1 may 
regulate Atp2c2c expression. Binding of MIST1 to Atp2c2 was observed in the region of 
exon 24, in the same area that binding of RNA Pol II was identified, suggesting that 
MIST1 is playing a role in activating gene transcription of Atp2c2c. A robust enrichment 
of the activation mark H3K4Me3 was also observed in this region of wild type mice, and 
this enrichment was lost and replaced with enrichment of the repressive mark H3K27Me3 
in Mist1-/- mice. This further supports the idea that MIST1 is a regulator of Atp2c2c 
expression.  
  Interestingly expression of MIST1 has been shown to play a role in differentiation 
of plasma cells in mouse and human downstream of XBP1. XBP1 also activates MIST1 
expression in pancreatic acinar cells and other secretory cells. Plasma cells also have a 
secretory function and MIST1 plays a role in activating expression in plasma cells of the 
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same secretory associated genes, as MIST1 activates in the secretory Chief Cells of the 
stomach (Capoccia et al., 2011). Rab3d and Rab26 have also been observed to be 
downstream transcriptional targets of MIST1, which are involved in vesicular secretion in 
regulated exocytosis by Chief cells and show similar changes in expression when MIST1 
is lost as those observed in Atp2c2 (Garside et al., 2010; Tian et al., 2010). Therefore 
Atp2c2c appears to be regulated by MIST1 though this is likely not the only regulator. 
Future experiments should aim to identify other potential regulators of Atp2c2 and 
explore where this gene is regulated differently in different tissues.  
 In conclusion, I have identified the TSS of Atp2c2c in pancreatic acinar cells and 
confirmed that Mist1 may be a regulator of Atp2c2c expression. It is important to 
understand how Ca2+ is regulated in pancreatic acinar cells because aberrant Ca2+ 
regulation has been associated with increased susceptibility and severity of pancreatic 
diseases (Voronina & Tepikin, 2012). Pancreatitis and pancreatic ductal adenocarcinoma 
severely reduce quality of life and life expectancy and insight into their potential 
mechanisms is crucial for improving outcomes (Anderson, Cotterchio, & Gallinger, 
2009).  
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1.27 Chromatin Immunoprecipitation Wash Buffers 	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
SDS Lysis Buffer 
1% SDS 
10mM EDTA 
50mM Tris pH 8.1 
  
Dilution Buffer 
0.5% Triton X-100 
2mM EDTA 
20mM Tris pH 8.1 
500mM NaCl 
  
Low Salt Wash Buffer 
0.1% SDS 
1% Triton X-100 
2mM EDTA 
20mM Tris pH 8.1 
150mM NaCl 
  
High Salt Wash Buffer 
0.1% SDS 
1% Triton X-100 
2mM EDTA 
20mM Tris HCl pH 8.1 
500mM NaCl 










LiCl Wash Buffer 
0.25M LiCl 
1% IGEPAL (octylphenoxypolyethoxyethanol) 
1% deoxycholate Na 
1mM EDTA 
10mM Tris pH 8.1 
  
TE Wash Buffer 
10mM Tris pH 8.1 
1mM EDTA 
!
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1.28 Primer Sequences for ChIP-PCR and ChIP-qPCR 	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  
















 L-Atp2c2 Reverse ATGCCTACACACACAGCAGG!






-3000 Atp2c2c Reverse (I) ATGGACTTCAACGGGTTGTC!







-1000 Atp2c2c Reverse (II) GGATGGACCCAATCAATCAC!






+167 Atp2c2c Reverse (III) ATGCCTACACACACAGCAGG!






+1500 Atp2c2c Reverse (IV) ACCCAAGGACTGAGTACAGGAA!








 +3800 Atp2c2c Reverse (V) TTGCCCTAGCTCTCCGAGTA!




1.29 pMK -2286/+1544-ATG 24- FLAG-SPCA2c sequence 	  	  
	  	  	  


































	  	  	  	  
1.31 pGL3−619 ATG 24-Promoter sequence 
	  	  
1.32 pGL3−309 ATG 24-Promoter sequence 
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